Polycystic ovary syndrome and risk of adverse obstetric outcomes: a retrospective population-based matched cohort study in England

被引：0
作者：
Anuradhaa Subramanian
Siang Ing Lee
Katherine Phillips
Konstantinos A. Toulis
Punith Kempegowda
Michael W. O’Reilly
Nicola J. Adderley
Shakila Thangaratinam
Wiebke Arlt
Krishnarajah Nirantharakumar
机构：
[1] University of Birmingham,Institute of Applied Health Research
[2] WHO Collaborating Centre for Global Women’s Health,Institute of Metabolism and Systems Research
[3] University of Birmingham,Endocrinology and Metabolism Unit, Department of Medicine
[4] Royal College of Surgeons in Ireland (RCSI),undefined
[5] University of Medicine and Health Sciences,undefined
[6] Birmingham Women’s and Children’s NHS Foundation Trust,undefined
[7] National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre,undefined
[8] University Hospitals Birmingham NHS Foundation Trust and University of Birmingham,undefined
[9] Midlands Health Data Research UK,undefined
来源：
BMC Medicine | / 20卷
关键词：
Polycystic ovary syndrome; PCOS; Preterm; Birthweight; Stillbirth; Delivery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 96 条
[1]  
Hillman SC(2018)Polycystic ovarian syndrome: an under-recognised problem? Br J Gen Pract 68 244-244
[2]  
Dale J(2016)Diagnosis and management of polycystic ovary syndrome in the UK (2004–2014): a retrospective cohort study BMJ Open 6 2841-2855
[3]  
Ding T(2016)The prevalence and phenotypic features of polycystic ovary syndrome: A systematic review and meta-Analysis Hum Reprod 31 2275-2284
[4]  
Baio G(2021)Diagnosis delayed: health profile differences between women with undiagnosed polycystic ovary syndrome and those with a clinical diagnosis by age 35 years Hum Reprod 36 1602-1618
[5]  
Hardiman PJ(2018)Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome Hum Reprod 33 214-221
[6]  
Petersen I(2020)Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity Clin. Chim. Acta. 502 R53-R65
[7]  
Sammon C(2017)MANAGEMENT OF ENDOCRINE DISEASE: Morbidity in polycystic ovary syndrome Eur J Endocrinol 176 e4863-558.e6
[8]  
Bozdag G(2016)Association between polycystic ovary syndrome and the risk of pregnancy complications A PRISMA-compliant systematic review and meta-analysis Med.  (United States). 95 67-14
[9]  
Mumusoglu S(2019)Transgenerational effects of polycystic ovary syndrome identified Nat Rev Endocrinol. 16 745-683
[10]  
Zengin D(2015)Complications and challenges associated with polycystic ovary syndrome: current perspectives Int J Womens Health 7 e1-1539
12345678910